Olympus, BioImagene ink patent contract

TriMed Staff | | Health Imaging | Oncology Imaging
Microscope imaging provider Olympus America has signed a nonexclusive worldwide licensing agreement with Sunnyvale, Calif.-based digital pathology provider BioImagene.

Via the terms of the agreement, BioImagene will be granted access to Olympus' portfolio of digital pathology and virtual microscopy patents, said the Center Valley, Pa.-based Olympus. The companies are not making specific terms and conditions of the agreement public.


TriMed Staff

Related Content

MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer
Breast cancer only visible via MRI is often less aggressive
Breast cancer rates are on the rise, new report reveals

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.